Your browser doesn't support javascript.
loading
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nik-Zainal, Serena; Davies, Helen; Staaf, Johan; Ramakrishna, Manasa; Glodzik, Dominik; Zou, Xueqing; Martincorena, Inigo; Alexandrov, Ludmil B; Martin, Sancha; Wedge, David C; Van Loo, Peter; Ju, Young Seok; Smid, Marcel; Brinkman, Arie B; Morganella, Sandro; Aure, Miriam R; Lingjærde, Ole Christian; Langerød, Anita; Ringnér, Markus; Ahn, Sung-Min; Boyault, Sandrine; Brock, Jane E; Broeks, Annegien; Butler, Adam; Desmedt, Christine; Dirix, Luc; Dronov, Serge; Fatima, Aquila; Foekens, John A; Gerstung, Moritz; Hooijer, Gerrit K J; Jang, Se Jin; Jones, David R; Kim, Hyung-Yong; King, Tari A; Krishnamurthy, Savitri; Lee, Hee Jin; Lee, Jeong-Yeon; Li, Yilong; McLaren, Stuart; Menzies, Andrew; Mustonen, Ville; O'Meara, Sarah; Pauporté, Iris; Pivot, Xavier; Purdie, Colin A; Raine, Keiran; Ramakrishnan, Kamna; Rodríguez-González, F Germán; Romieu, Gilles.
Afiliação
  • Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. snz@sanger.ac.uk.
  • Davies H; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 9NB, UK. snz@sanger.ac.uk.
  • Staaf J; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Ramakrishna M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
  • Glodzik D; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Zou X; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Martincorena I; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Alexandrov LB; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Martin S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Wedge DC; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA.
  • Van Loo P; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA.
  • Ju YS; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Smid M; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Brinkman AB; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Morganella S; Department of Human Genetics, University of Leuven, B-3000, Leuven, Belgium.
  • Aure MR; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Lingjærde OC; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
  • Langerød A; Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA, Nijmegen, The Netherlands.
  • Ringnér M; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
  • Ahn SM; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
  • Boyault S; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
  • Brock JE; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
  • Broeks A; Department of Computer Science, University of Oslo, Oslo, Norway.
  • Butler A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310, Norway.
  • Desmedt C; K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0310, Norway.
  • Dirix L; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, SE-223 81, Sweden.
  • Dronov S; Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea.
  • Fatima A; Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373, Lyon Cedex 08, France.
  • Foekens JA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA.
  • Gerstung M; The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands.
  • Hooijer GKJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Jang SJ; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000, Brussels, Belgium.
  • Jones DR; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Kim HY; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • King TA; Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
  • Krishnamurthy S; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, 3015CN, The Netherlands.
  • Lee HJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Lee JY; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Li Y; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
  • McLaren S; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Menzies A; Department of Pathology, College of Medicine, Hanyang University, Seoul, 133-791, South Korea.
  • Mustonen V; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10065, USA.
  • O'Meara S; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas, 77030, USA.
  • Pauporté I; Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea.
  • Pivot X; Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea.
  • Purdie CA; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Raine K; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Ramakrishnan K; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Rodríguez-González FG; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
  • Romieu G; Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
Nature ; 566(7742): E1, 2019 02.
Article em En | MEDLINE | ID: mdl-30659290
ABSTRACT
In the Methods section of this Article, 'greater than' should have been 'less than' in the sentence 'Putative regions of clustered rearrangements were identified as having an average inter-rearrangement distance that was at least 10 times greater than the whole-genome average for the individual sample. '. The Article has not been corrected.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido